Tag Archives: Prostate Cancer
Chennai: Global Hospitals on Saturday inaugurated the country’s first wide-bore 3T Silent Scan MRI with MAGiC, which can reportedly reduce scan time by as much as 67%, at its hospital in Perumbakkam, Chennai. The hospital also inaugurated GE Healthcare’s Discovery IQ PET/CT system that can assist in diagnosis, staging and post treatment monitoring of cancer.
London: An Indian-origin doctor in Britain has been suspended and is facing an investigation over the treatment he gave to cancer patients, a media report said.
London: Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment, according to research published in the journal Cancer Cell.
New York (IANS): A new urine-based test has improved prostate cancer detection compared to traditional methods, says a study.
Kolkata (IANS): Paving the way for personalised medicine, Indian scientists have identified for the first time various genetic alterations found in prostate cancer patients in the country, a development that could aid clinicians diagnose, decide and select the most effective and precise therapy for the person.
Washington: Having a family history of prostate cancer among first-degree relatives may increase a woman’s risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
New Delhi: Cancer comes without warning. It does not give the victims an alarm to be alert and approach a cancer specialist as soon as it attacks them. Because of this mysterious character of this disease, as many as five lakh people are dying from cancer every year in India, according to a World Cancer Report from the World Health Organisation.
Moscow: Russian scientists have developed a vaccine for the treatment of cancer that can increase the patient’s lifespan more than two-fold, ITAR-TASS reported on Wednesday.
Bangalore: The US Food and Drug Administration (FDA) has accepted the novel molecule of the Bangalore-based Jubilant Biosys for clinical trials to treat prostate cancer, the pharma company said on Saturday.